Standardized, batch-inspected botanical extracts and clean-label hard capsules engineered to meet stringent Japanese MHLW and Food Sanitation Act specifications for Kobe distributors and brand manufacturers.
Navigating the intersection of traditional Kampo wisdom, modern regenerative medicine, and cutting-edge pharmaceutical ecosystems within the Kansai economic corridor.
Situated near Port Island, KBIC is Japan's largest biomedical research hub. Our standardized extracts—such as Trans-Resveratrol 98% and Alpha GPC—supply clinical trials, preclinical cell models, and mitochondrial metabolic investigations conducted by university spinoffs and translational pharmacology ventures across Hyogo Prefecture.
Kobe consumers balance historic Kampo therapies with western preventive nutraceuticals. We supply high-potency bio-enhancers, including botanical-grade Apigenin and Lion's Mane Beta-Glucans, facilitating harmonized finished formulations that respect both traditional Han-fang tonic principles and modern clinical pharmacokinetic requirements.
Japan's Consumer Affairs Agency enforces stringent biomarker validation for "Kinousei Hyouji Shokuhin". Our factory provides fully traceable, pesticide-screened botanical ingredients with quantified active compounds (such as naturally fermented GABA 99% for cognitive stress attenuation) enabling seamless dossier submissions for Kansai brand developers.
Empirical insights into regulatory shifts, port logistical efficiencies, and demographic evolutions transforming Kobe's health supplement ecosystem.
Hyogo Prefecture possesses one of Japan's most rapidly expanding demographic profiles for seniors aged 65+. The demand curve has migrated from generic multivitamins to targeted neuro-support, bone mineral stability (Micro-chelated Calcium & K2), and synaptic health (Magnesium L-Threonate), challenging brands to deploy higher bioavailability formats.
Importing botanical extracts directly through the Port of Kobe mitigates the congestion typically encountered at Tokyo/Yokohama customs terminals. Direct maritime routes from Chinese export hubs provide expedited customs transit for temperature-sensitive phytonutrients, optimizing raw material freshness and lowering regional freight storage overheads.
Kansai retail pharmacy chains strictly audit excipient profiles. Formulators demand botanical powders milled to ultra-fine mesh (80–120 mesh) that encapsulate seamlessly into non-GMO hypromellose (HPMC) plant-derived shells without relying on titanium dioxide, synthetic silicon dioxide, or magnesium stearate.
Combining 19 years of verified extraction infrastructure with international compliance protocols to de-risk overseas nutraceutical procurement.
Audited under NSF 455-2 GMP, ISO 22000, HACCP, and verified on-site by TÜV Rheinland with full validation traceability.
Every batch undergoes HPLC/UV active assay confirmation, ICP-MS heavy metal screen (Pb, Cd, As, Hg), and microbial bioburden plating.
Pilot clinical runs from 100 to 500 units for capsules, scaling smoothly to multi-million commercial runs with standardized batch replication.
Standardized issuance of complete COAs, flowcharts, non-irradiation declarations, and TSE/BSE statements to expedite quarantine clearances.
Headquarters
GMP Cleanroom
Extraction Lines
Analytical Testing
Primary Packing
Logistics Center
Detailed operational responses resolving compliance, testing, formulation, and customs requirements for Japanese trading companies and nutraceutical brands.
We subject all raw botanical harvest batches to rigorous multi-residue screening via LC-MS/MS and GC-MS/MS, calibrated specifically against the Ministry of Health, Labour and Welfare (MHLW) Positive List System. We verify that over 450 pesticide analytes fall below the default uniform limit (0.01 ppm) or specific agricultural chemical standards prior to release.
Our regulatory team cross-references all botanical species, plant parts used (e.g., root vs. aerial parts), and concentration ratios against the MHLW "List of Non-Medicinal Ingredients" (Non-Drug List) versus the "Medicinal Ingredient List". We ensure your imported items are legally classified as food supplements to allow streamlined declaration and sale without requiring Japanese pharmaceutical licensure.
Yes. We formulate extensively with pharmaceutical-grade vegetarian hydroxypropyl methylcellulose (HPMC) capsules derived from natural pine wood cellulose. These capsules contain zero animal byproducts (eliminating TSE/BSE quarantine queries), no carrageenan, no synthetic preservatives, and are certified non-GMO, satisfying Japanese clean-label retail demands.
Every shipment arrives with a complete compliance packet: Manufacturer Certificate of Analysis (COA) specifying botanical assay markers, detailed manufacturing process flowcharts, Certificate of Origin (COO), heavy metal and microbiological certificates, animal-origin-free statements, and non-radiation guarantees essential for Quarantine Stations (Ken-ekisho) clearance.
Absolutely. Our R&D team customizes exact extract yields to correspond to scientific evidence dossiers. For instance, if your clinical systematic review establishes efficacy at 100 mg of GABA or 250 mg of Lion's Mane standardized extract, we standardize blend homogeneity and unit fill volume to guarantee verified label compliance over the entire product shelf-life.
Standard OEM capsule production takes approximately 15 to 25 business days following formula approval and packaging proof sign-off. Transit from our facility via Qingdao/Shanghai freight corridors directly to the Port of Kobe typically requires only 3 to 5 days on ocean transit, minimizing inventory downtime for local distribution hubs.
Whether formulating a functional dietary capsule or qualifying bulk pharmaceutical-grade extracts for Kobe distribution networks, ESNO Biotech delivers documented analytical purity, rapid pilot sampling, and dedicated account support.